Understanding Carbapenem Antibiotics in Critical Care

Carbapenems are a subclass of β-lactam antibiotics characterised by a bicyclic core: a β-lactam ring fused with a five-membered pyrroline ring containing a carbon atom in place of the sulphur found in penicillins. This structural variation gives carbapenems a broad antibacterial spectrum and high stability against many bacterial enzymes that inactivate other β-lactams.

Common agents in this class include meropenem, imipenem (always combined with cilastatin), ertapenem, and doripenem. In hospital settings these agents are typically reserved for serious or complicated infections and are governed by antimicrobial stewardship programmes to slow the emergence of resistance.

Under India's Drugs and Cosmetics Rules, 1945, meropenem and most other carbapenems are classified as Schedule H1 drugs — a sub-schedule of Schedule H that applies to certain antibiotics, anti-TB drugs, and habit-forming substances.

Schedule H1 imposes additional retail requirements: the drug must be dispensed against the prescription of a Registered Medical Practitioner (RMP); the retailer must maintain a separate Schedule H1 register recording the patient's name, the prescriber, and the quantity supplied; and the package must carry the Schedule H1 warning text along with a red vertical line on the left margin of the label.

Most carbapenems are supplied as sterile lyophilized or powder-filled vials for I.V. reconstitution shortly before administration. Storage requirements typically specify temperatures not exceeding 30°C and protection from light and moisture; refer to the Indian Pharmacopoeia monograph for each agent for exact handling conditions.

For a distribution network, this implies cold-chain or controlled-room-temperature handling from the manufacturer's QC release through to dispatch, dock receipt at the hospital pharmacy, and any short hold at the stockist level. Batch numbering and expiry tracking are essential for traceability in case of a recall.

When evaluating a carbapenem supplier, hospital procurement and PCD distribution partners typically check three things: a verifiable CDSCO drug distribution licence (not just a brand claim); IP-compliant batch documentation provided per dispatch; and dispatch reliability evidenced by consistent on-time delivery and clear lot/expiry tracking.

ALTRAVAX distributes carbapenem injectables under CDSCO Distribution Licenses DL000504 and DL000511. Available SKUs in this class are listed in the catalogue.